remifentanil has been researched along with Hypoxia-Ischemia, Brain in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, WB; Wang, J | 1 |
1 other study(ies) available for remifentanil and Hypoxia-Ischemia, Brain
| Article | Year |
|---|---|
Remifentanil alleviates hypoxic-ischemic brain damage-induced cognitive impairment via BACH1.
Topics: Animals; Animals, Newborn; Basic-Leucine Zipper Transcription Factors; Brain; BTB-POZ Domain; Cognitive Dysfunction; Hypoxia-Ischemia, Brain; NF-kappa B; Rats; Remifentanil; TNF Receptor-Associated Factor 3 | 2022 |